| Q2 2024 |
83 |
$419M |
+$44.2M |
-$15.6M |
+$28.6M |
XBI, STXS, MRUS, CYTK, RVMD
|
13F-HR |
8/14/2024, 01:46 PM |
| Q1 2024 |
72 |
$439M |
+$34.4M |
-$82.5M |
-$48.1M |
XBI, STXS, CYTK, IDYA, MRUS
|
13F-HR |
5/15/2024, 02:16 PM |
| Q4 2023 |
76 |
$417M |
+$37.5M |
-$52.2M |
-$14.8M |
XBI, CYTK, STXS, IDYA, SNDX
|
13F-HR |
2/14/2024, 02:02 PM |
| Q3 2023 |
75 |
$321M |
+$40.4M |
-$44.4M |
-$3.96M |
XBI, STXS, CYTK, IDYA, RVMD
|
13F-HR |
11/14/2023, 02:29 PM |
| Q2 2023 |
73 |
$366M |
+$36.7M |
-$35.8M |
+$932K |
XBI, ISEE, STXS, BPMC, RVMD
|
13F-HR |
8/14/2023, 02:05 PM |
| Q1 2023 |
72 |
$334M |
+$26.1M |
-$29.1M |
-$2.99M |
XBI, STXS, ISEE, ASND, KRTX
|
13F-HR |
5/15/2023, 01:24 PM |
| Q4 2022 |
79 |
$355M |
+$31.9M |
-$58.3M |
-$26.5M |
XBI, STXS, ASND, KRTX, IBB
|
13F-HR |
2/14/2023, 02:24 PM |
| Q3 2022 |
87 |
$371M |
+$15.8M |
-$44.2M |
-$28.4M |
XBI, STXS, BPMC, BHVNXXXX, ASND
|
13F-HR |
11/14/2022, 02:14 PM |
| Q2 2022 |
90 |
$367M |
+$79.3M |
-$19.4M |
+$59.9M |
XBI, STXS, BHVNXXXX, ACET, FATE
|
13F-HR |
8/15/2022, 02:35 PM |
| Q1 2022 |
94 |
$384M |
+$93.4M |
-$17.4M |
+$76M |
STXS, XBI, FATE, BPMC, ACET
|
13F-HR |
5/16/2022, 02:22 PM |
| Q4 2021 |
87 |
$398M |
+$51.4M |
-$38.4M |
+$13M |
STXS, BPMC, FATE, ACET, XENE
|
13F-HR |
2/14/2022, 01:56 PM |
| Q3 2021 |
80 |
$377M |
+$35.8M |
-$52.3M |
-$16.5M |
STXS, BPMC, FATE, BHVNXXXX, DRNA
|
13F-HR |
11/15/2021, 01:52 PM |
| Q2 2021 |
84 |
$478M |
+$50.7M |
-$32.8M |
+$17.9M |
STXS, FATE, DRNA, BPMC, TBPH
|
13F-HR |
8/16/2021, 03:13 PM |
| Q1 2021 |
89 |
$421M |
+$83.5M |
-$27.2M |
+$56.4M |
STXS, FATE, BPMC, DRNA, SAGE
|
13F-HR |
5/17/2021, 02:02 PM |
| Q4 2020 |
74 |
$336M |
+$33M |
-$82.4M |
-$49.4M |
STXS, FATE, BPMC, SAGE, DRNA
|
13F-HR |
2/16/2021, 02:21 PM |
| Q3 2020 |
80 |
$308M |
+$32.3M |
-$57.3M |
-$25M |
STXS, IMMU, BPMC, FATE, ARCT
|
13F-HR |
11/16/2020, 01:59 PM |
| Q2 2020 |
87 |
$347M |
+$57.5M |
-$53.3M |
+$4.2M |
STXS, BPMC, FATE, ARNA, DRNA
|
13F-HR |
8/14/2020, 01:52 PM |
| Q1 2020 |
80 |
$240M |
+$48.8M |
-$31.3M |
+$17.4M |
STXS, BPMC, FATE, GLPG, DXCM
|
13F-HR |
5/15/2020, 03:05 PM |
| Q4 2019 |
81 |
$291M |
+$20.9M |
-$55.5M |
-$34.7M |
STXS, PRQR, ATRC, ARQL, BPMC
|
13F-HR |
2/14/2020, 04:01 PM |
| Q3 2019 |
89 |
$266M |
+$34M |
-$15.1M |
+$18.9M |
STXS, SAGE, ALDR, BPMC, GLPG
|
13F-HR |
11/14/2019, 04:59 PM |
| Q2 2019 |
87 |
$266M |
+$43.6M |
-$11.5M |
+$32M |
STXS, SAGE, BPMC, ATRC, ALDR
|
13F-HR |
8/14/2019, 02:39 PM |
| Q1 2019 |
79 |
$232M |
+$31.2M |
-$55.5M |
-$24.3M |
STXS, SAGE, BPMC, ATRC, ALDR
|
13F-HR |
5/15/2019, 02:49 PM |
| Q4 2018 |
83 |
$201M |
+$24.4M |
-$10.3M |
+$14.1M |
LOXO, STXS, SAGE, ATRC, NXTM
|
13F-HR |
2/14/2019, 03:18 PM |
| Q3 2018 |
75 |
$244M |
+$22.7M |
-$14.7M |
+$8.04M |
LOXO, STXS, SAGE, ATRC, NXTM
|
13F-HR |
11/14/2018, 01:37 PM |
| Q2 2018 |
75 |
$214M |
+$23.1M |
-$42.6M |
-$19.5M |
LOXO, SAGE, STXS, AERI, NXTM
|
13F-HR |
8/10/2018, 07:31 PM |
| Q1 2018 |
75 |
$206M |
+$47.4M |
-$49.3M |
-$1.86M |
LOXO, SAGE, STXS, BPMC, ATRC
|
13F-HR |
5/15/2018, 12:52 PM |
| Q4 2017 |
72 |
$186M |
+$40.2M |
-$15.2M |
+$25M |
LOXO, BPMC, ATRC, AERI, ARGX
|
13F-HR |
2/13/2018, 05:48 PM |
| Q3 2017 |
73 |
$161M |
+$27M |
-$26.2M |
+$800K |
LOXO, ATRC, BGNE, IMMU, BCRX
|
13F-HR |
11/14/2017, 03:37 PM |
| Q2 2017 |
75 |
$140M |
+$22.1M |
-$9.15M |
+$13M |
LOXO, ATRC, IMMU, AERI, NXTM
|
13F-HR |
8/14/2017, 04:41 PM |
| Q1 2017 |
72 |
$118M |
+$25.2M |
-$28.1M |
-$2.91M |
LOXO, ATRC, NXTM, ALDR, BCRX
|
13F-HR |
5/15/2017, 12:09 PM |
| Q4 2016 |
66 |
$114M |
+$19.9M |
-$43.1M |
-$23.3M |
ATRC, NXTM, ALDR, LOXO, GLPG
|
13F-HR |
2/14/2017, 02:44 PM |
| Q3 2016 |
74 |
$144M |
+$25.6M |
-$41.9M |
-$16.3M |
VTAE, CYNA, ATRC, NXTM, TNDM
|
13F-HR |
11/14/2016, 01:00 PM |
| Q2 2016 |
94 |
$125M |
+$26.5M |
-$24.6M |
+$1.92M |
NXTM, ATRC, VTAE, DERM, ABBV
|
13F-HR |
8/15/2016, 04:34 PM |
| Q1 2016 |
93 |
$116M |
+$41.3M |
-$11.5M |
+$29.8M |
ATRC, ABBV, NXTM, VTAE, RIGL
|
13F-HR |
5/16/2016, 01:35 PM |
| Q4 2015 |
77 |
$112M |
+$19.1M |
-$17.6M |
+$1.43M |
ATRC, NXTM, ABBV, MRNS, PODD
|
13F-HR |
2/12/2016, 05:00 PM |
| Q3 2015 |
88 |
$101M |
+$15.1M |
-$23.6M |
-$8.53M |
ATRC, ABBV, NXTM, ZSPH, ACHN
|
13F-HR |
11/13/2015, 01:23 PM |
| Q2 2015 |
76 |
$117M |
+$33.9M |
-$51.7M |
-$17.8M |
ATRC, ABBV, NXTM, ACHN, RIGL
|
13F-HR |
8/14/2015, 02:47 PM |
| Q1 2015 |
70 |
$130M |
+$19.3M |
-$39.9M |
-$20.5M |
PCYC, ATRC, ASPX, NXTM, DSCO
|
13F-HR |
5/14/2015, 06:08 PM |
| Q4 2014 |
62 |
$126M |
+$25.1M |
-$9.38M |
+$15.7M |
PCYC, ATRC, ASPX, NXTM, DSCO
|
13F-HR |
2/13/2015, 06:30 PM |
| Q3 2014 |
59 |
$99.1M |
+$19M |
-$12.2M |
+$6.84M |
PCYC, DSCO, ATRC, NXTM, PODD
|
13F-HR |
11/13/2014, 06:24 PM |
| Q2 2014 |
49 |
$106M |
+$11.2M |
-$12.7M |
-$1.5M |
AMPE, ATRC, PCYC, DSCO, NXTM
|
13F-HR |
8/14/2014, 05:24 PM |
| Q1 2014 |
46 |
$116M |
+$24.8M |
-$16.3M |
+$8.51M |
DSCO, PCYC, ATRC, AMPE, NVDQ
|
13F-HR |
5/14/2014, 06:38 PM |
| Q4 2013 |
47 |
$97.2M |
$0 |
$0 |
|
DSCO, PCYC, ATRC, STXS, GIVN
|
13F-HR |
2/13/2014, 07:08 PM |